Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
34291 | 113 | 37.4 | 78% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
5 | 4 | CHEMISTRY, ORGANIC//CHEMISTRY, INORGANIC & NUCLEAR//CHEMISTRY, MULTIDISCIPLINARY | 1745167 |
558 | 3 | EBSELEN//DIPHENYL DISELENIDE//CIENCIAS NAT EXATAS | 17618 |
1633 | 2 | EBSELEN//DIPHENYL DISELENIDE//CIENCIAS NAT EXATAS | 6970 |
34291 | 1 | SAFDIE AIDS IMMUNOL//AS101//CAIR | 113 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | SAFDIE AIDS IMMUNOL | address | 4611273 | 20% | 74% | 23 |
2 | AS101 | authKW | 4503769 | 18% | 83% | 20 |
3 | CAIR | address | 1088425 | 21% | 17% | 24 |
4 | MARILYN FINKLER CANC | address | 360301 | 2% | 67% | 2 |
5 | 2 ETHANEDIOLATO O | authKW | 270227 | 1% | 100% | 1 |
6 | 2D QSAR HQSAR ANALYSIS | authKW | 270227 | 1% | 100% | 1 |
7 | 4 METHYLENE 3 1 BENZOAXIN 2 ONE | authKW | 270227 | 1% | 100% | 1 |
8 | 6NEUROPROTECTION | authKW | 270227 | 1% | 100% | 1 |
9 | AIDS IMMUNOL CAIR | address | 270227 | 1% | 100% | 1 |
10 | AMMONIUM TRICHLORO1 | authKW | 270227 | 1% | 100% | 1 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Immunology | 216 | 22% | 0% | 25 |
2 | Oncology | 64 | 14% | 0% | 16 |
3 | Cell Biology | 40 | 12% | 0% | 13 |
4 | Hematology | 36 | 6% | 0% | 7 |
5 | Chemistry, Medicinal | 27 | 5% | 0% | 6 |
6 | Chemistry, Inorganic & Nuclear | 24 | 6% | 0% | 7 |
7 | Chemistry, Organic | 22 | 8% | 0% | 9 |
8 | Biochemistry & Molecular Biology | 15 | 14% | 0% | 16 |
9 | Medicine, Research & Experimental | 14 | 5% | 0% | 6 |
10 | Pharmacology & Pharmacy | 13 | 9% | 0% | 10 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | SAFDIE AIDS IMMUNOL | 4611273 | 20% | 74% | 23 |
2 | CAIR | 1088425 | 21% | 17% | 24 |
3 | MARILYN FINKLER CANC | 360301 | 2% | 67% | 2 |
4 | AIDS IMMUNOL CAIR | 270227 | 1% | 100% | 1 |
5 | FISH GENET IMMUNOL | 270227 | 1% | 100% | 1 |
6 | INTERDISIPLINARY | 270227 | 1% | 100% | 1 |
7 | RAOUL WALLENBERG CHAIR IMMUNOCHEM | 270227 | 1% | 100% | 1 |
8 | RAOUL WALLENBERG CHAIR IMMUNOL CHEM | 270227 | 1% | 100% | 1 |
9 | SAFDI AIDS IMMUNOL | 270227 | 1% | 100% | 1 |
10 | SAFDIE CANC | 270227 | 1% | 100% | 1 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | NATURAL IMMUNITY AND CELL GROWTH REGULATION | 6925 | 2% | 1% | 2 |
2 | NATURAL IMMUNITY | 1942 | 1% | 1% | 1 |
3 | ZEITSCHRIFT FUR KRISTALLOGRAPHIE-CRYSTALLINE MATERIALS | 1788 | 1% | 1% | 1 |
4 | EXPERIMENTAL HEMATOLOGY | 753 | 4% | 0% | 4 |
5 | PATHOPHYSIOLOGY OF HAEMOSTASIS AND THROMBOSIS | 747 | 1% | 0% | 1 |
6 | JOURNAL OF INFLAMMATION-LONDON | 698 | 1% | 0% | 1 |
7 | NEUROMOLECULAR MEDICINE | 482 | 1% | 0% | 1 |
8 | KOREAN JOURNAL OF PARASITOLOGY | 350 | 1% | 0% | 1 |
9 | BIOLOGICAL CHEMISTRY | 335 | 2% | 0% | 2 |
10 | RESEARCH COMMUNICATIONS IN MOLECULAR PATHOLOGY AND PHARMACOLOGY | 324 | 1% | 0% | 1 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | AS101 | 4503769 | 18% | 83% | 20 | Search AS101 | Search AS101 |
2 | 2 ETHANEDIOLATO O | 270227 | 1% | 100% | 1 | Search 2+ETHANEDIOLATO+O | Search 2+ETHANEDIOLATO+O |
3 | 2D QSAR HQSAR ANALYSIS | 270227 | 1% | 100% | 1 | Search 2D+QSAR+HQSAR+ANALYSIS | Search 2D+QSAR+HQSAR+ANALYSIS |
4 | 4 METHYLENE 3 1 BENZOAXIN 2 ONE | 270227 | 1% | 100% | 1 | Search 4+METHYLENE+3+1+BENZOAXIN+2+ONE | Search 4+METHYLENE+3+1+BENZOAXIN+2+ONE |
5 | 6NEUROPROTECTION | 270227 | 1% | 100% | 1 | Search 6NEUROPROTECTION | Search 6NEUROPROTECTION |
6 | AMMONIUM TRICHLORO1 | 270227 | 1% | 100% | 1 | Search AMMONIUM+TRICHLORO1 | Search AMMONIUM+TRICHLORO1 |
7 | AS101 IMMUNOMODULATOR | 270227 | 1% | 100% | 1 | Search AS101+IMMUNOMODULATOR | Search AS101+IMMUNOMODULATOR |
8 | ENATIOPURE | 270227 | 1% | 100% | 1 | Search ENATIOPURE | Search ENATIOPURE |
9 | HIGH RESOLUTION POSITIVE ION DESORPTION CHEMICAL IONIZATION | 270227 | 1% | 100% | 1 | Search HIGH+RESOLUTION+POSITIVE+ION+DESORPTION+CHEMICAL+IONIZATION | Search HIGH+RESOLUTION+POSITIVE+ION+DESORPTION+CHEMICAL+IONIZATION |
10 | IMMUNOMODULATION AGENTS | 270227 | 1% | 100% | 1 | Search IMMUNOMODULATION+AGENTS | Search IMMUNOMODULATION+AGENTS |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | SREDNI, B , (2012) IMMUNOMODULATING TELLURIUM COMPOUNDS AS ANTI-CANCER AGENTS.SEMINARS IN CANCER BIOLOGY. VOL. 22. ISSUE 1. P. 60-69 | 29 | 28% | 25 |
2 | CARMELY, A , MEIROW, D , PERETZ, A , ALBECK, M , BARTOOV, B , SREDNI, B , (2009) PROTECTIVE EFFECT OF THE IMMUNOMODULATOR AS101 AGAINST CYCLOPHOSPHAMIDE-INDUCED TESTICULAR DAMAGE IN MICE.HUMAN REPRODUCTION. VOL. 24. ISSUE 6. P. 1322-1329 | 17 | 50% | 15 |
3 | HALPERT, G , SREDNI, B , (2014) THE EFFECT OF THE NOVEL TELLURIUM COMPOUND AS101 ON AUTOIMMUNE DISEASES.AUTOIMMUNITY REVIEWS. VOL. 13. ISSUE 12. P. 1230 -1235 | 23 | 30% | 7 |
4 | FRIEDMAN, M , BAYER, I , LETKO, I , DUVDEVANI, R , ZAVARO-LEVY, O , RON, B , ALBECK, M , SREDNI, B , (2009) TOPICAL TREATMENT FOR HUMAN PAPILLOMAVIRUS-ASSOCIATED GENITAL WARTS IN HUMANS WITH THE NOVEL TELLURIUM IMMUNOMODULATOR AS101: ASSESSMENT OF ITS SAFETY AND EFFICACY.BRITISH JOURNAL OF DERMATOLOGY. VOL. 160. ISSUE 2. P. 403 -408 | 13 | 62% | 8 |
5 | ALBECK, A , WEITMAN, H , SREDNI, B , ALBECK, M , (1998) TELLURIUM COMPOUNDS: SELECTIVE INHIBITION OF CYSTEINE PROTEASES AND MODEL REACTION WITH THIOLS.INORGANIC CHEMISTRY. VOL. 37. ISSUE 8. P. 1704 -1712 | 19 | 54% | 63 |
6 | SILBERMAN, A , ALBECK, M , SREDNI, B , ALBECK, A , (2016) LIGAND-SUBSTITUTION REACTIONS OF THE TELLURIUM COMPOUND AS-101 IN PHYSIOLOGICAL AQUEOUS AND ALCOHOLIC SOLUTIONS.INORGANIC CHEMISTRY. VOL. 55. ISSUE 21. P. 10847 -10850 | 11 | 58% | 0 |
7 | PIOVAN, L , ALVES, MFM , JULIANO, L , BROMME, D , CUNHA, RLOR , ANDRADE, LH , (2011) STRUCTURE-ACTIVITY RELATIONSHIPS OF HYPERVALENT ORGANOCHALCOGENANES AS INHIBITORS OF CYSTEINE CATHEPSINS V AND S.BIOORGANIC & MEDICINAL CHEMISTRY. VOL. 19. ISSUE 6. P. 2009 -2014 | 16 | 39% | 5 |
8 | YOSEF, S , BRODSKY, M , SREDNI, B , ALBECK, A , ALBECK, M , (2007) OCTA-O-BIS-(R,R)-TARTARATE DITELLURANE (SAS) - A NOVEL BIOACTIVE ORGANOTELLURIUM(IV) COMPOUND: SYNTHESIS, CHARACTERIZATION, AND PROTEASE INHIBITORY ACTIVITY.CHEMMEDCHEM. VOL. 2. ISSUE 11. P. 1601-1606 | 15 | 45% | 11 |
9 | DANOCH, H , KALECHMAN, Y , ALBECK, M , LONGO, DL , SREDNI, B , (2015) SENSITIZING B- AND T- CELL LYMPHOMA CELLS TO PACLITAXEL/ABRAXANE-INDUCED DEATH BY AS101 VIA INHIBITION OF THE VLA-4-IL10-SURVIVIN AXIS.MOLECULAR CANCER RESEARCH. VOL. 13. ISSUE 3. P. 411 -422 | 16 | 35% | 1 |
10 | CARACELLI, I , VEGA-TEIJIDO, M , ZUKERMAN-SCHPECTOR, J , CEZARI, MHS , LOPES, JGS , JULIANO, L , SANTOS, PS , COMASSETO, JV , CUNHA, RLOR , TIEKINK, ERT , (2012) A TELLURIUM-BASED CATHEPSIN B INHIBITOR: MOLECULAR STRUCTURE, MODELLING, MOLECULAR DOCKING AND BIOLOGICAL EVALUATION.JOURNAL OF MOLECULAR STRUCTURE. VOL. 1013. ISSUE . P. 11 -18 | 21 | 27% | 7 |
Classes with closest relation at Level 1 |